The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
p38 MAP kinase inhibition ameliorates cisplatin nephrotoxicity in mice
Abstract
Cisplatin is an important chemotherapeutic agent but can cause acute renal injury. Part of this acute renal injury is mediated through tumor necrosis factor-α (TNF-α). The pathway through which cisplatin mediates the production of TNF-α and injury is not known. Cisplatin activates p38 MAPK and induces apoptosis in cancer cells. p38 MAPK activation leads to increased production of TNF-α in ischemic injury and in macrophages. However, little is known concerning the role of p38 MAPK in cisplatin-induced renal injury. Therefore, we examined the effect of cisplatin on p38 MAPK activity and the role of p38 MAPK in mediating cisplatin-induced TNF-α production and renal injury. In vitro, cisplatin caused a dose-dependent activation of p38 MAPK in proximal tubule cells. Inhibition of p38 MAPK activation led to inhibition of TNF-α production. In vivo, mice treated with a single dose of cisplatin (20 mg/kg body wt) developed severe renal dysfunction at 72 h [blood urea nitrogen (BUN): 154 ± 34 mg/dl, creatinine: 1.4 ± 0.4 mg/dl], which was accompanied by an increase in kidney p38 MAPK activity and an increase in infiltrating leukocytes. However, animals treated with the p38 MAPK inhibitor SKF-86002 along with cisplatin showed less renal dysfunction (BUN: 55 ± 14 mg/dl, creatinine: 0.3 ± 0.02 mg/dl, P < 0.05), less severe histological damage, and fewer leukocytes compared with cisplatin+vehicle-treated animals. Serum levels of TNF-α, sTNFRI, and sTNFRII also increased significantly in cisplatin-treated mice compared with SKF-86002-treated mice ( P < 0.05). Kidney mRNA levels of TNF-α were significantly increased in cisplatin-treated mice compared with either SKF-86002- or saline-treated animals. The hydroxyl radical scavenger DMTU (100 mg·kg body wt−1·day−1) prevented the activation of p38 MAPK by cisplatin both in vitro and in vivo. DMTU also completely prevented cisplatin-induced renal injury (BUN: 140 ± 27 vs. 22 ± 2 mg/dl, P < 0.005) and the increase in serum TNF-α (33 ± 7 vs. 4 ± 2 pg/ml, P < 0.005) and kidney TNF-α mRNA in vivo. We conclude that hydroxyl radicals, either directly or indirectly, activate p38 MAPK and that p38 MAPK plays an important role in mediating cisplatin-induced acute renal injury and inflammation, perhaps through production of TNF-α.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Opposing Effects of ERK and JNK-p38 MAP Kinases on Apoptosis
Xia, Z., Dickens, M., Raingeaud, J., Davis, R. J., & Greenberg, M. E. (1995) · Science · doi:10.1126/science.270.5240.1326 · Cited by 5,287
Mammalian MAP kinase signalling cascades
Chang, L., & Karin, M. (2001) · Nature · doi:10.1038/35065000 · Cited by 5,111
A protein kinase involved in the regulation of inflammatory cytokine biosynthesis
Lee, J. C., Laydon, J. T., McDonnell, P. C., Gallagher, T. F., Kumar, S., Green, D., McNulty, D., Blumenthal, M. J., Keys, J. R., Land vatter, S. W., et al. (1994) · Nature · doi:10.1038/372739a0 · Cited by 3,288
Ichijo, H., Nishida, E., Irie, K., Dijke, P. T., Saitoh, M., Moriguchi, T., Takagi, M., Matsumoto, K., Miyazono, K., & Gotoh, Y. (1997) · Science · doi:10.1126/science.275.5296.90 · Cited by 2,307
Activation of Mitogen-activated Protein Kinase by H2O2
Guyton, K. Z., Liu, Y., Gorospe, M., Xu, Q., & Holbrook, N. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.8.4138 · Cited by 1,212
TNF-α mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity
Ramesh, G., & Reeves, W. B. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15606 · Cited by 866
Self-citationLebwohl, D., & Canetta, R. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00224-x · Cited by 754
Acute renal failure: definitions, diagnosis, pathogenesis, and therapy
Schrier, R. W., Wang, W., Poole, B., & Mitra, A. (2004) · Journal of Clinical Investigation · doi:10.1172/jci22353 · Cited by 683
Requirement for ERK Activation in Cisplatin-induced Apoptosis
Wang, X., Martindale, J. L., & Holbrook, N. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004583200 · Cited by 675
Acute renal failure: definitions, diagnosis, pathogenesis, and therapy
Schrier, R. W., Wang, W., Poole, B., & Mitra, A. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422353 · Cited by 642
Antibody to intercellular adhesion molecule 1 protects the kidney against ischemic injury.
Kelly, K. J., Williams, W. W., Colvin, R. B., & Bonventre, J. V. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.2.812 · Cited by 489
Interleukin-10 inhibits ischemic and cisplatin-induced acute renal injury
Deng, J., Kohda, Y., Chiao, H., Wang, Y., Hu, X., Hewitt, S. M., Miyaji, T., Mcleroy, P., Nibhanupudy, B., Li, S., et al. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00043.x · Cited by 399
Mansouri, A., Ridgway, L. D., Korapati, A. L., Zhang, Q., Tian, L., Wang, Y., Siddik, Z. H., Mills, G. B., & Claret, F. X. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208134200 · Cited by 377
Tissue-specific Pattern of Stress Kinase Activation in Ischemic/Reperfused Heart and Kidney
Yin, T., Sandhu, G., Wolfgang, C. D., Burrier, A., Webb, R. L., Rigel, D. F., Hai, T., & Whelan, J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.32.19943 · Cited by 364
Pathophysiological role of T lymphocytes in renal ischemia-reperfusion injury in mice
Rabb, H., Daniels, F., O'Donnell, M., Haq, M., Saba, S. R., Keane, W., & Tang, W. W. (2000) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2000.279.3.f525 · Cited by 352
Park, K. M., Chen, A., & Bonventre, J. V. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007518200 · Cited by 326
In vitro and in vivo evidence suggesting a role for iron in cisplatin-induced nephrotoxicity
Baliga, R., Zhang, Z., Baliga, M., Ueda, N., & Shah, S. V. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00767.x · Cited by 297
Effect of Extracellular Signal-regulated Kinase on p53 Accumulation in Response to Cisplatin
Persons, D. L., Yazlovitskaya, E. M., & Pelling, J. C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004267200 · Cited by 290
Frevel, M. A. E., Bakheet, T., Silva, A. M., Hissong, J. G., Khabar, K. S. A., & Williams, B. R. G. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.2.425-436.2003 · Cited by 288
TNFR2-mediated apoptosis and necrosis in cisplatin-induced acute renal failure
Ramesh, G., & Reeves, W. B. (2003) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00101.2003 · Cited by 282
Self-citationOxidant mechanisms in toxic acute renal failure
Baliga, R., Ueda, N., Walker, P. D., & Shah, S. V. (1997) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(97)90212-2 · Cited by 274
Megyesi, J., Safirstein, R. L., & Price, P. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1497 · Cited by 272
Nowak, G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206373200 · Cited by 265
Agarwal, A., Balla, J., Alam, J., Croatt, A. J., & Nath, K. A. (1995) · Kidney International · doi:10.1038/ki.1995.414 · Cited by 260
Kontoyiannis, D. (2001) · The EMBO Journal · doi:10.1093/emboj/20.14.3760 · Cited by 255
Peus, D., Vasa, R. A., Beyerle, A., Meves, A., Krautmacher, C., & Pittelkow, M. R. (1999) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1999.00584.x · Cited by 244
Tsuruya, K., Ninomiya, T., Tokumoto, M., Hirakawa, M., Masutani, K., Taniguchi, M., Fukuda, K., Kanai, H., Kishihara, K., Hirakata, H., et al. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00709.x · Cited by 241
Persons, D. L., Yazlovitskaya, E. M., Cui, W., & Pelling, J. C. (1999) · PubMed · Cited by 237
Cisplatin-induced cell death is EGFR/src/ERK signaling dependent in mouse proximal tubule cells
Arany, I., Megyesi, J. K., Kaneto, H., Price, P. M., & Safirstein, R. L. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00112.2004 · Cited by 215
Salicylate reduces cisplatin nephrotoxicity by inhibition of tumor necrosis factor-α
Ramesh, G., & Reeves, W. B. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00413.x · Cited by 196
Self-citationMatsuzawa, A., & Ichijo, H. (2001) · Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a002947 · Cited by 172
Liu, H., & Baliga, R. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00908.x · Cited by 171
CL100/MKP-1 modulates JNK activation and apoptosis in response to cisplatin
Sánchez‐Pérez, I., Martínez-Gomáriz, M., Williams, D. J., Keyse, S. M., & Perona, R. (2000) · Oncogene · doi:10.1038/sj.onc.1203887 · Cited by 142
Protection of renal cells from cisplatin toxicity by cell cycle inhibitors
Price, P. M., Safirstein, R. L., & Megyesi, J. K. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00192.2003 · Cited by 134
Inhibitors of Protein Kinase Signaling Pathways
Force, T. L., Kuida, K., Namchuk, M., Parang, K., & Kyriakis, J. M. (2004) · Circulation · doi:10.1161/01.cir.0000118538.21306.a9 · Cited by 128
Expression and function of P-glycoprotein in a mouse kidney cell line
Ernest, S., & Bello-Reuss, E. N. (1995) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1995.269.2.c323 · Cited by 126
Heterogeneity in Control of mRNA Stability by AU-rich Elements
Tebo, J. M., Der, S., Frevel, M. A. E., Khabar, K. S. A., Williams, B. R. G., & Hamilton, T. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212992200 · Cited by 120
Hoffmeyer, A., Große-Wilde, A., Flory, E., Neufeld, B., Kunz, M., Rapp, U. R., & Ludwig, S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.7.4319 · Cited by 115
Meldrum, K. K., Meldrum, D. R., Hile, K. L., Yerkes, E. B., Ayala, A., Cain, M. P., Rink, R. C., Casale, A. J., & Kaefer, M. A. (2001) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2001.281.2.c563 · Cited by 112
Role of cytochrome P-450 as a source of catalytic iron in cisplatin-induced nephrotoxicity
Baliga, R., Zhang, Z., Baliga, M., Ueda, N., & Shah, S. V. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00161.x · Cited by 110
Tsuruya, K., Tokumoto, M., Ninomiya, T., Hirakawa, M., Masutani, K., Taniguchi, M., Fukuda, K., Kanai, H., Hirakata, H., & Iida, M. (2003) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00311.2002 · Cited by 107
Furuichi, K., Wada, T., Iwata, Y., Sakai, N., Yoshimoto, K., KOBAYASHI, K. P., Mukaida, N., Matsushima, K., & Yokoyama, H. (2002) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/17.3.399 · Cited by 69
Ye, J., Zeidler-Erdely, P. C., Young, S., Martinez, A., Robinson, V. A., Jones, W. G., Baron, P. A., Shi, X., & Castranova, V. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008814200 · Cited by 32
Khadaroo, R. G., Parodo, J. C., Powers, K. A., Papia, G., Marshall, J. C., Kapùs, A., & Rotstein, O. D. (2003) · Surgery · doi:10.1067/msy.2003.228 · Cited by 27
Cited by
Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies
Pabla, N., & Dong, Z. (2008) · Kidney International · doi:10.1038/sj.ki.5002786 · Cited by 1,918
Mechanisms of Cisplatin Nephrotoxicity
Miller, R. P., Tadagavadi, R. K., Ramesh, G., & Reeves, W. B. (2010) · Toxins · doi:10.3390/toxins2112490 · Cited by 1,622
Self-citationCisplatin Nephrotoxicity: A Review
Yao, X., Panichpisal, K., Kurtzman, N., & Nugent, K. (2007) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e31812dfe1e · Cited by 1,251
Pathophysiology of Cisplatin-Induced Acute Kidney Injury
Ozkok, A., & Edelstein, C. L. (2014) · BioMed Research International · doi:10.1155/2014/967826 · Cited by 703
Oxidant Mechanisms in Renal Injury and Disease
Ratliff, B. B., Abdulmahdi, W., Pawar, R., & Wolin, M. S. (2016) · Antioxidants & Redox Signaling · doi:10.1089/ars.2016.6665 · Cited by 694
Metadata
- Authors
- Ramesh, G., & Reeves, W. B.
- Venue
- American Journal of Physiology-Renal Physiology
- Publisher
- American Physiological Society
- Published
- 2005-07
- Volume
- 289
- Issue
- 1
- Pages
- F166-F174
- ISSN
- 1522-1466 (ISSN-L)
- 1931-857X
- OpenAlex
- W2100714950
- Cited by
- 267
- References
- 44
- FWCI
- 7.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.